Carmen D. Zorrilla to Infectious Disease Transmission, Vertical
This is a "connection" page, showing publications Carmen D. Zorrilla has written about Infectious Disease Transmission, Vertical.
Connection Strength
1.806
-
Zorrilla CD, Rodr?guez-Figueroa L, Miranda-De Le?n S, L?pez-Alvarado B, P?rez E, Rabionet SE. Elimination of the Perinatal Transmission of HIV and Syphilis in Puerto Rico and Sustained Success since 2007: Convergence of Science, Women-Centered Care, and Policy. P R Health Sci J. 2021 03; 40(1):12-18.
Score: 0.737
-
Zorrilla CD, Tamayo Agrait V, Febo I, Santiago LE, D?az C, Salabarr?a I, P?rez E, Hillyer GV. Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine. P R Health Sci J. 2007 Dec; 26(4):329-35.
Score: 0.294
-
Zorrilla CD. HIV infection in women: perinatal issues and cervical cancer surveillance. Top HIV Med. 2007 Feb-Mar; 15(1):1-5.
Score: 0.278
-
Silva-Su?rez G, Bastida E, Rabionet SE, Beck-Sagu? C, Febo I, Zorrilla CD. "That's True Love:" Lived Experiences of Puerto Rican Perinatally HIV-Infected Youth within Their Families' Context. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010007.
Score: 0.129
-
Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jim?nez E, McSherry G, Mofenson L. Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants. Antimicrob Agents Chemother. 2007 Jun; 51(6):2208-10.
Score: 0.070
-
Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J. Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr. 2005 Sep 01; 40(1):30-3.
Score: 0.063
-
Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):87-95.
Score: 0.060
-
Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr. 2003 Feb 01; 32(2):170-81.
Score: 0.053
-
Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS, Matzen E, Landay A, Zorrilla C, Blattner W, Charurat M, Anderson DJ. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
Score: 0.053
-
Ramgopal M, Osiyemi O, Zorrilla C, Crauwels HM, Ryan R, Brown K, Hillewaert V, Baugh B. Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women. J Acquir Immune Defic Syndr. 2016 11 01; 73(3):268-274.
Score: 0.034
-
Chen KT, Tuomala RE, Chu C, Huang ML, Watts DH, Zorrilla CD, Paul M, Hershow R, Larussa P. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol. 2008 Apr; 198(4):399.e1-5.
Score: 0.019
-
Navas-Nacher EL, Read JS, Leighty RM, Tuomala RE, Zorrilla CD, Landesman S, Rosenblatt H, Hershow RC. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS. 2006 Feb 14; 20(3):429-36.
Score: 0.016